News    Matrix-Bio Names Goonewardene to Board of Directors

Matrix-Bio Names Goonewardene to Board of Directors

Posted May 6, 2013 by Matrix-Bio • No Comments


FORT WAYNE, IND., May 16, 2013 – Matrix-Bio, Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has named Julie K. Goonewardene to its Board of Directors.

Download PDF


No Comments

No comments yet.

Sorry, the comment form is closed at this time.


CONNECT WITH MATRIX-BIO

If you have questions about Matrix-Bio’s early liver cancer detection test or about our investing and partnership opportunities, please contact:

Eric Beier, MD, MBA
ebeier@matrix-bio.com